EBS - Emergent Biosolutions - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

EBS is currently covered by 2 analysts with an average price target of $11. This is a potential upside of $4.67 (73.78%) from yesterday's end of day stock price of $6.33.

Emergent Biosolutions's activity chart (see below) currently has 110 price targets and 101 ratings on display. The stock rating distribution of EBS is 80% BUY and 20% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 65.53% with an average time for these price targets to be met of 151.79 days.

Highest price target for EBS is $12, Lowest price target is $10, average price target is $11.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 09-Sep-2026. First documented stock forecast 27-Sep-2017.

Currently out of the existing stock ratings of EBS, 4 are a BUY (80%), 1 are a SELL (20%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 30-Dec-2024

$10

$3.67 (57.98%)

$10

24 days ago
(09-Sep-2026)

0/14 (0%)

$4.32 (76.06%)

Sell Since 20-Nov-2023

1 months 12 days ago
(21-Aug-2026)

2/3 (66.67%)

$0.88 (10.84%)

7

Buy Since 11-Apr-2024

$12

$3.47 (40.68%)

$8

1 years 10 months 26 days ago
(07-Nov-2024)

7/11 (63.64%)

$1 (9.09%)

72

Buy Since 13-Sep-2024

$16

$9.67 (152.76%)

$23

2 years 20 days ago
(13-Sep-2024)

10/15 (66.67%)

$8.13 (103.30%)

135

Hold Since 12-Sep-2022

$15

$8.67 (136.97%)

$29

3 years 4 months 14 days ago
(19-May-2023)

4/8 (50%)

$6.83 (83.60%)

86

Show more analysts

Please expand the browser size to see the chart

What is EBS (Emergent Biosolutions) average time for price targets to be met?

On average it took 152 days for the stock forecasts to be reached, with an average price target met ratio of 65.53%.

Which analyst most recently updated their price target on EBS (Emergent Biosolutions)?

Raghuram Selvaraju

Which analyst has the most public recommendations on EBS (Emergent Biosolutions)?

Raghuram Selvaraju works at HC WAINWRIGHT and has 17 price targets and 17 ratings on EBS

Which analyst is the currently most bullish on EBS (Emergent Biosolutions)?

Dana Flanders with the highest potential upside of $94.67

Which analyst is the currently most reserved on EBS (Emergent Biosolutions)?

David Maris with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?